Dr. Lawrie asked Hill to explain his U-turn on ivermectin, which his own analysis found overwhelmingly effective. “How can you do this?” she inquired politely. “You are causing irreparable harm.”
Hill explained that he was in a “tricky situation,” because his sponsors had put pressure on him. Hill is a University of Liverpool virologist who serves as an advisor to Bill Gates and the Clinton Foundation. “He told me his sponsor was Unitaid.” Unitaid is a quasi-governmental advocacy organization funded by the BMGF and several European countries—France, the United Kingdom, Norway, Brazil, Spain, the Republic of Korea, and Chile—to lobby governments to finance the purchase of medicines from pharmaceutical multinationals for distribution to the African poor. Its primary purpose seems to be protecting the patent and intellectual property rights of pharmaceutical companies—which, as we shall see, is the priority passion for Bill Gates—and to insure their prompt and full payment. About 63 percent of its funding comes from a surtax on airline tickets. The Bill & Melinda Gates Foundation holds a board seat and chairs Unitaid’s Executive Committee, and the BMGF has given Unitaid $150 million since 2005.62 Various Gates-funded surrogate and front organizations, like Global Fund, Gavi, and UNICEF also contribute, as does the pharmaceutical industry. The BMGF and Gates personally own large stakes in many of the pharmaceutical companies that profit from this boondoggle. Gates also uses Unitaid to fund corrupt science by tame and compromised researchers like Hill that legitimizes his policy directives to the WHO. Unitaid gave $40 million to Andrew Hill’s employer, the University of Liverpool, four days before the publication of Hill’s study.
Hill, a PhD, confessed that the sponsors were pressuring him to influence his conclusion. When Dr. Lawrie asked who was trying to influence him, Hill said, “I mean, I, I think I’m in a very sensitive position here. . . .”
Dr. Tess Lawrie, MD, PhD: “Lots of people are in sensitive positions; they’re in hospital, in ICUs dying, and they need this medicine.”
Dr. Hill: “Well. . . .”
Dr. Tess Lawrie: “This is what I don’t get, you know, because you’re not a clinician. You’re not seeing people dying every day. And this medicine prevents deaths by 80 percent. So 80 percent of those people who are dying today don’t need to die because there’s ivermectin.”
Dr. Andrew Hill: “There are a lot, as I said, there are a lot of different opinions about this. As I say, some people simply. . . .”
Dr. Tess Lawrie: “We are looking at the data; it doesn’t matter what other people say. We are the ones who are tasked with . . . look[ing] at the data and reassur[ing] everybody that this cheap and effective treatment will save lives. It’s clear. You don’t have to say, well, so-and-so says this, and so-and-so says that. It’s absolutely crystal clear. We can save lives today. If we can get the government to buy ivermectin.”
Dr. Andrew Hill: “Well, I don’t think it’s as simple as that, because you’ve got trials. . . .”
Dr. Tess Lawrie: “It is as simple as that. We don’t have to wait for studies . . . we have enough evidence now that shows that ivermectin saves lives, it prevents hospitalization. It saves the clinical staff going to work every day, [and] being exposed. And frankly, I’m shocked at how you are not taking responsibility for that decision. And you still haven’t told me who is [influencing you]? Who is giving you that opinion? Because you keep saying you’re in a sensitive position. I appreciate you are in a sensitive position, if you’re being paid for something and you’re being told [to support] a certain narrative . . . that is a sensitive position. So, then you kind of have to decide, well, do I take this payment? Because in actual fact, [you] can see [your false] conclusions . . . are going to harm people. So maybe you need to say, I’m not going to be paid for this. I can see the evidence, and I will join the Cochrane team as a volunteer, like everybody on the Cochrane team is a volunteer. Nobody’s being paid for this work.”
Dr. Andrew Hill: “I think fundamentally, we’re reaching the [same] conclusion about the survival benefit. We’re both finding a significant effect on survival.”
Dr. Tess Lawrie: “No, I’m grading my evidence. I’m saying I’m sure of this evidence. I’m saying I’m absolutely sure it prevents deaths. There is nothing as effective as this treatment. What is your reluctance? Whose conclusion is that?” Hill then complains again that outsiders are influencing him.
Dr. Tess Lawrie: “You keep referring to other people. It’s like you don’t trust yourself. If you were to trust yourself, you would know that you have made an error and you need to correct it because you know, in your heart, that this treatment prevents death.”
Dr. Andrew Hill: “Well, I know, I know for a fact that the data right now is not going to get the drug approved.”
Dr. Tess Lawrie: “But, Andy—know this will come out . . . It will come out that there were all these barriers to the truth being told to the public and to the evidence being presented. So please, this is your opportunity just to acknowledge [the truth] in your review, change your conclusions, and come on board with this Cochrane Review, which will be definitive. It will be the review that shows the evidence and gives the proof. This was the consensus on Wednesday night’s meeting with 20 experts.” Hill protests that NIH will not agree to recommend IVM.
Dr. Tess Lawrie: “Yeah, because the NIH is owned by the vaccine lobby.”
Dr. Andrew Hill: “That’s not something I know about.”
Dr. Tess Lawrie: “Well, all I’m saying is this smacks of corruption and you are being played.”
Dr. Hill: “I don’t think so.”
Dr. Tess Lawrie: “Well then, you have no excuse because your work in that review is flawed. It’s rushed. It is not properly put together.” Dr. Lawrie points out that Hill’s study ignores a host of clinical outcomes that affect patients.
She scolds Hill for ignoring the beneficial effects of IVM as prophylaxis, its effect on speed to PCR negativity, on the need for mechanical ventilation, on reduced admissions to ICUs, and other outcomes that are clinically meaningful.
She adds, “This is bad research . . . bad research. So, at this point, I don’t know . . . you seem like a nice guy, but I am really, really worried about you.”
Dr. Andrew Hill: “Okay. Yeah. I mean, it’s, it’s a difficult situation.”
Dr. Tess Lawrie: “No, you might be in a difficult situation. I’m not, because I have no paymaster. I can tell the truth . . . How can you deliberately try and mess it up . . . you know?”
Dr. Andrew Hill: “It’s not messing it up. It’s saying that we need, we need a short time to look at some more studies.”
Dr. Tess Lawrie: “So, how long are you going to let people carry on dying unnecessarily—up to you? What is, what is the timeline that you’ve allowed for this, then?”